View Older Stories View More Recent Stories
-
Cooper Companies (COO) PT Lowered to $99 at Needham
-
William Blair Resumes Cooper Companies (COO) at Outperform
-
KeyBanc on Medical Technology: 'From Reset to Rebound?'
-
Cooper Companies (COO) Reiterated at Buy by Stifel: Well-Positioned with SiHy Dailies
-
Cooper Cos. names CFO Andrews as principal accounting officer
-
Cooper Companies (COO) PT Raised to $100 at Mizuho
-
Cooper Companies (COO) PT Raised to $100 at Needham
-
KeyBanc on Cooper Companies (COO): 'Encouraged by Incremental Actions Heading into 2026'
-
Cooper Companies (COO) PT Raised to $95 at Stifel
-
CooperCompanies names new board chair, launches strategic review
-
Browning West urges Cooper Companies board overhaul, strategic review
-
Stifel Says Cooper Companies' (COO) Surgical Business Solid; Potential in MiSight Lens, MM Portfolio
-
Barclays Starts Cooper Companies (COO) at Overweight
-
Goldman Sachs Starts Cooper Companies (COO) at Sell
-
Stifel Reiterates Buy Rating on Cooper Companies (COO)
-
Cooper Cos. (COO) call put ratio 1 calls to 1.3 puts as share price down 10%
-
KeyBanc on Cooper Companies (COO): 'Resetting FY25 Growth Outlook Again'
-
Cooper Companies (COO) PT Lowered at Piper Sandler After 'Another Disappointing CVI Quarter'
-
Cooper Companies (COO) PT Lowered to $85 at Stifel
-
Cooper Cos. (COO) Tops Q3 EPS by 4c, Offers Guidance
-
Stifel Reiterates Buy Rating on Cooper Companies (COO)
-
Needham Upgrades Cooper Companies (COO) to Buy
-
Stifel Reiterates Buy Rating on Cooper Companies (COO)
-
Nephron Downgrades Cooper Companies (COO) to Hold
-
Cooper Companies (COO) PT Lowered at Piper Sandler; 'The Negativity is Overdone'
-
JPMorgan Downgrades Cooper Companies (COO) to Neutral
-
Needham Reiterates Hold Rating on Cooper Companies (COO)
-
Piper Sandler Reiterates Overweight Rating on Cooper Companies (COO)
-
Citi shuffles MedTech stocks: BDX downgraded, ITGR raised; reiterates top pick
-
These 2 sectors are under-owned, Barclays says and advises where to invest
-
Cooper Cos. (COO) Appoints Barbara Carbone to its Board
-
Stifel highlights medical technology stocks with best risk/reward
-
Cooper Companies (COO) PT Lowered to $105 at Stifel
-
Cooper Companies (COO) PT Lowered to $115 at Piper Sandler
-
Needham Reiterates Hold Rating on Cooper Companies (COO)
-
Cooper Companies (COO) PT Lowered to $110 at Jefferies
-
KeyBanc on Cooper Companies (COO): 'Some Moving Pieces to Begin FY25'
-
Cooper Cos. (COO) Reports In-Line Q1 EPS, provides guidance
-
IVF stocks on watch as President Trump signs an executive order to expand access
-
Stifel Reiterates Buy Rating on Cooper Companies (COO)
-
Cooper Companies (COO) PT Lowered to $115 at Citi
-
Cooper Cos. (COO) Tops Q4 EPS by 4c, Offers Guidance
-
Piper Sandler Reiterates Overweight Rating on Cooper Companies (COO)
-
Cooper Companies (COO) PT Raised to $120 at Mizuho
-
KeyBanc Reiterates Sector Weight Rating on Cooper Companies (COO)
-
Piper Sandler Reiterates Overweight Rating on Cooper Companies (COO)
-
Cooper Companies (COO) PT Raised to $125 at Baird
-
Piper Sandler highlights 'undervalued' Medtech stock; Earnings to be positive catalyst
-
Piper Sandler Reiterates Overweight Rating on Cooper Companies (COO)
-
These stocks offer you exposure to rising demand for fertility treatment – Barclays

